logo
#

Latest news with #All-Access

Kamada Is Bringing Relief To Those With Rare And Serious Conditions
Kamada Is Bringing Relief To Those With Rare And Serious Conditions

Associated Press

time16-04-2025

  • Business
  • Associated Press

Kamada Is Bringing Relief To Those With Rare And Serious Conditions

By Johnny Rice Benzinga DETROIT, MICHIGAN - April 16, 2025 ( NEWMEDIAWIRE ) - Amir London, CEO of Kamada Pharmaceuticals (NASDAQ: KMDA), was recently a guest on Benzinga's All-Access. Kamada is a global biopharmaceutical company with a portfolio of assets indicated for rare and serious conditions. The company reports it is a leader in the specialty plasma-derived field, focused on diseases with limited treatment alternatives. Mr. London was on the program to discuss exciting developments in the company's development pipeline as well as Mr. London's strategy for M&A. Watch the full interview here: Featured photo byHal GatewoodonUnsplash. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. This content was originallypublished on Benzinga. Read further disclosureshere.

Innovation Helps This CleanTech Company Weather The Current Market
Innovation Helps This CleanTech Company Weather The Current Market

Associated Press

time09-04-2025

  • Business
  • Associated Press

Innovation Helps This CleanTech Company Weather The Current Market

DETROIT, MICHIGAN - April 9, 2025 ( NEWMEDIAWIRE) - Dennis Calvert, President & CEO of BioLargo Inc. (OTC: BLGO), was recently a guest on Benzinga's All-Access. BioLargo is a cleantech and life sciences innovator and engineering services solution provider. Its core products address Per- and Polyfluorinated Substances (PFAS) contamination, achieve advanced water and wastewater treatment, provide safe, long-lasting battery energy storage, control odor and Volatile Organic Compounds (VOCs), improve air quality and control infections and infectious diseases. Mr. Calvert spoke of his company's ability to weather turbulent markets through its technological innovation. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.

Revolutionizing Fan Engagement With Sportradar
Revolutionizing Fan Engagement With Sportradar

Associated Press

time26-03-2025

  • Business
  • Associated Press

Revolutionizing Fan Engagement With Sportradar

DETROIT, MICHIGAN - March 26, 2025 ( NEWMEDIAWIRE) - Carsten Koerl, CEO of Sportradar (NASDAQ: SRAD), was recently a guest on Benzinga's All-Access. Sportradar (NASDAQ: SRAD) wants to revolutionize the sports fan and betting experience through its comprehensive technology solutions. The platform connects sports federations, media companies and betting operators with cutting-edge data analytics, visualization tools and integrity services. Organizations worldwide rely on Sportradar's solutions to enhance engagement, provide real-time insights and maintain sporting integrity across major leagues and competitions.

Implantable, Hidden Continuous Glucose Monitoring Could Revolutionize Diabetes Care
Implantable, Hidden Continuous Glucose Monitoring Could Revolutionize Diabetes Care

Associated Press

time19-03-2025

  • Business
  • Associated Press

Implantable, Hidden Continuous Glucose Monitoring Could Revolutionize Diabetes Care

DETROIT, MICHIGAN - March 19, 2025 ( NEWMEDIAWIRE) - Paul Goode, President & CEO, GlucoTrack (NASDAQ: GCTK), was recently a guest on Benzinga's All-Access. GlucoTrack is a medical technology company whose two-year implantable Continuous Blood Glucose Monitoring (CBGM) technology provides discreet, accurate, real-time glucose readings. The company's vision is to create a future where diabetes management is automatic and inconspicuous, empowering people to live boldly and unapologetically.

AI Has Great Power - Data Security Is A Must
AI Has Great Power - Data Security Is A Must

Associated Press

time18-03-2025

  • Business
  • Associated Press

AI Has Great Power - Data Security Is A Must

DETROIT, MICHIGAN - March 18, 2025 ( NEWMEDIAWIRE) - Paul Chang, Global President of Brand Engagement Network, Inc. (NASDAQ: BNAI), or BEN, & Carl DeMaio, California State Representative, were recently guests on Benzinga's All-Access. BEN is a provider of conversational AI technology and human-like AI avatars. The company delivers highly personalized AI engagement with a focus on industries where there may be a large workforce gap and an opportunity to transform how consumers engage with networks, providers and brands. The company is a key advisor of Representative DeMaio's bill, the 'Stop Foreign Governments from Accessing Californians' Sensitive Personal Data Act.' Featured photo by Steve Johnson on Unsplash.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store